What does Brii Biosciences invest in?
Brii Biosciences invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Infectious Diseases and Central Nervous System Diseases.
United States · Investor
Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCompany
2 rounds on record
Mostly Series A: 100% of its rounds
Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challengesFrom their own website
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies Brii Biosciences put money into.
Brii Biosciences invests most often at Series A (100% of the rounds on record), in sectors such as Biotechnology, Infectious Diseases and Central Nervous System Diseases.
2 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019.
Its most recent investments on record: AN2 (Series A, Nov 2019) and Artizan Biosciences (Series A, Jun 2019).
The median round it joins is $12M.
No investments in the last 12 months; the latest was in Nov 2019.
Brii Biosciences is a company based in United States.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it